Experiences of Antiretroviral Therapy Initiation Among HIV-Positive Adults in Ethiopia: A Descriptive Phenomenological Design

References

• Boyd MA, Boffito M, Castagna A, Estrada V. Rapid initiation of antiretroviral therapy at HIV diagnosis: definition, process, knowledge gaps. HIV Med. 2019;1:3–11. doi:10.1111/hiv.12708
   Web of Science ®Google Scholar
• Joint United Nations Programme on HIV/AIDS. On the fast-track to end AIDS; 2021. Available from: https://www.unaids.org/en/resources/fact-sheet. Accessed September 15, 2021.
   Google Scholar
• Bellissimo F, Pinzone MR, Celesia BM, Cacopardo B, Nunnari G. Baseline CD4/CD8 T-Cell ratio predicts prompt immune restoration upon cART initiation. Curr HIV Res. 2016;14(6):491–496. doi:10.2174/1570162X14666160414111554
   PubMed Web of Science ®Google Scholar
• Henn A, Flateau C, Gallien S. Primary HIV infection: clinical presentation, testing, and treatment. Curr Infect Dis Rep. 2017;19(10):37. doi:10.1007/s11908-017-0588-3
   PubMed Web of Science ®Google Scholar
• Tran M, Wood E, Kerr T, et al. Increases in CD4+ T-cell count at antiretroviral therapy initiation among HIV-positive illicit drug users during a treatment-as-prevention initiative in Canada. Antivir Ther. 2017;22(5):403–411. doi:10.3851/IMP3145
   PubMed Web of Science ®Google Scholar
• Council USO of ARA. Panel on antiretroviral guidelines for adults and adolescents; 2019. Available from: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf. Accessed May 17, 2022.
   Google Scholar
• Taramasso L, Demma F, Bitonti R, et al. How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy. BMC Health Serv Res. 2018;18(1):1–8. doi:10.1186/s12913-018-3507-x
   PubMed Web of Science ®Google Scholar
• Leveson N, Samost A, Dekker S, Finkelstein S, Raman J. A Systems approach to analyzing and preventing hospital adverse events. J Patient Saf. 2020;16(2):162–167. doi:10.1097/PTS.0000000000000263
   PubMed Web of Science ®Google Scholar
• DeClercq J, Rutsaert S, De Scheerder M-A, Verhofstede C, Callens S, Vandekerckhove L. Benefits of antiretroviral therapy initiation during acute HIV infection. Acta Clin Belg. 2020;77:1–9.
   PubMed Web of Science ®Google Scholar
• Kawuma R, Seeley J, Mupambireyi Z, Cowan F, Bernays S. The REALITY trial team. “Treatment is not yet necessary”: delays in seeking access to HIV treatment in Uganda and Zimbabwe. African J AIDS Res. 2018;17(3):217–225. doi:10.2989/16085906.2018.1490785
   PubMed Web of Science ®Google Scholar
• Bukenya D, Wringe A, Moshabela M, et al. Where are we now? A multicountry qualitative study to explore access to pre-antiretroviral care services: a precursor to antiretroviral therapy initiation. Sex Transm Infect. 2017;93(3):e052970. doi:10.1136/sextrans-2016-052970
   PubMed Web of Science ®Google Scholar
• Belay GM, Endalamaw A, Ayele AD. Late presentation of HIV positive adults and its predictors to HIV/AIDS care in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):534. doi:10.1186/s12879-019-4156-3
   PubMed Web of Science ®Google Scholar
• Bayisa L, Tadesse A, Reta MM, Gebeye E. Prevalence and factors associated with delayed Initiation of antiretroviral therapy among people living with HIV in Nekemte Referral Hospital, Western Ethiopia. HIV/AIDS. 2020;12:457–465.
   Google Scholar
• Gebru T, Lentiro K, Jemal A. Perceived behavioural predictors of late initiation to HIV/AIDS care in Gurage zone public health facilities: a cohort study using health belief model. BMC Res Notes. 2018;11(1):336. doi:10.1186/s13104-018-3408-4
   PubMedGoogle Scholar
• Nash D, Tymejczyk O, Gadisa T, Kulkarni SG. Factors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013. J Int AIDS Soc. 2016;19(1):20637. doi:10.7448/IAS.19.1.20637
   PubMed Web of Science ®Google Scholar
• Palella FJJ, Armon C, Chmiel JS, et al. CD4 cell count at initiation of ART, long-term likelihood of achieving CD4 >750 cells/mm3 and mortality risk. J Antimicrob Chemother. 2016;71(9):2654–2662. doi:10.1093/jac/dkw196
   PubMed Web of Science ®Google Scholar
• Earnshaw VA, Bogart LM, Courtney I, et al. Exploring treatment needs and expectations for people living with HIV in South Africa: a qualitative study. AIDS Behav. 2018;22(8):2543–2552. doi:10.1007/s10461-018-2101-x
   PubMed Web of Science ®Google Scholar
• Franse CB, Kayigamba FR, Bakker MI, et al. Linkage to HIV care before and after the introduction of provider-initiated testing and counselling in six Rwandan health facilities. AIDS Care. 2017;29(3):326–334. doi:10.1080/09540121.2016.1220475
   PubMed Web of Science ®Google Scholar
• Patel RC, Odoyo J, Anand K, et al. Facilitators and barriers of antiretroviral therapy initiation among HIV discordant couples in Kenya: qualitative insights from a pre-exposure prophylaxis implementation study. PLoS One. 2016;11(12):e0168057–e0168057. doi:10.1371/journal.pone.0168057
   PubMed Web of Science ®Google Scholar
• Adams AK, Zamberia AM. “I will take ARVs once my body deteriorates”: an analysis of Swazi men’s perceptions and acceptability of test and start. African J AIDS Res. 2017;16(4):295–303. doi:10.2989/16085906.2017.1362015
   PubMed Web of Science ®Google Scholar
• Pell C, Reis R, Dlamini N, Moyer E, Vernooij E. “Then her neighbour will not know her status”: how health providers advocate antiretroviral therapy under universal test and treat. Int Health. 2019;11(1):36–41. doi:10.1093/inthealth/ihy058
   PubMed Web of Science ®Google Scholar
• Seeley J, Bond V, Yang B, et al. Understanding the time needed to link to care and start ART in seven HPTN 071 (PopART) study communities in Zambia and South Africa. AIDS Behav. 2019;23(4):929–946. doi:10.1007/s10461-018-2335-7
   PubMed Web of Science ®Google Scholar
• Poku RA, Owusu AY, Mullen PD, Markham C, McCurdy SA. Antiretroviral therapy maintenance among HIV-positive women in Ghana: the influence of poverty. AIDS Care. 2020;32(6):779–784. doi:10.1080/09540121.2019.1653434
   PubMed Web of Science ®Google Scholar
• Haacker M, Birungi C. Poverty as a barrier to antiretroviral therapy access for people living with HIV/AIDS in Kenya. African J AIDS Res. 2018;17(2):145–152. doi:10.2989/16085906.2018.1475401
   PubMed Web of Science ®Google Scholar
• Assen A, Molla F, Wondimu A, et al. Late presentation for diagnosis of HIV infection among HIV positive patients in South Tigray Zone, Ethiopia. BMC Public Health. 2016;16(1):558. doi:10.1186/s12889-016-3263-y
   PubMed Web of Science ®Google Scholar
• Kebaabetswe P, Manyake K, Kadima E, et al. Barriers and facilitators to linkage to care and ART initiation in the setting of high ART coverage in Botswana. AIDS Care. 2020;32(6):722–728. doi:10.1080/09540121.2019.1640843
   PubMed Web of Science ®Google Scholar
• Manyazewal TM. Using the World Health Organization health system building blocks through survey of healthcare professionals to determine the performance of public healthcare facilities; 2017:75. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651704/. Accessed May 17, 2022.
   Google Scholar
• Fuge TG, Tsourtos G, Miller ER. Various structural factors influenced early antiretroviral therapy initiation amongst HIV infected prisoners: a qualitative exploration in South Ethiopia. BMC Public Health. 2021;21(1):1463. doi:10.1186/s12889-021-11499-w
   PubMed Web of Science ®Google Scholar
• Asghari S, Hurd J, Marshall Z, et al. Challenges with access to healthcare from the perspective of patients living with HIV: a scoping review & framework synthesis. AIDS Care. 2018;30(8):963–972. doi:10.1080/09540121.2018.1435848
   PubMed Web of Science ®Google Scholar
• World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. 2nd ed. Geneva, Switzerland: World Health Organization; 2016.
   Google Scholar
• Federal Ministry Of Health. National Consolidated Guidelines for Comprehensive HIV Prevention, Care and Treatment. 5th ed. Addis Ababa, Ethiopia: Federal Ministry of Health; 2018.
   Google Scholar
• Given LM. The SAGE Encyclopedia of Qualitative Research Methods. Vol. 2. Thousand Oaks: SAGE Publications, Inc.; 2008.
   Google Scholar
• Gerrish K, Lacey A, eds. The Research Process in Nursing. 7th ed. Chichester: Blackwell; 2017.
   Google Scholar
• Polit DF, Beck CT. Essential of Nursing Research: Appraising Evidence for Nursing Practice. 9th ed. Philadelphia: Wolters Kluwer Health; 2018.
   Google Scholar
• Latunde YC, ed. Qualitative Research Methods BT. Research in Parental Involvement Methods and Strategies for Education and Psychology. New York: Palgrave Macmillan US; 2017:97–112.
   Google Scholar
• West Shoa city administration. Health Management Information System Third Quarter Report. Vol. 24. Ambo, Ethiopia: National Health Mission; 2019.
   Google Scholar
• World Health Organization. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Recommendations for a Public Health Approach. Geneva, Switzerland: World Health Organization; 2010.
   Google Scholar
• Creswell JW, Creswell JD. Research Design: Qualitative, Quantitative and Mixed Approaches. 5th ed. California: Sage Publications, Inc.; 2018.
   Google Scholar
• Colaizzi PF. Psychological Research as a Phenomenologist Views It. Existential Phenomenological Alternatives for Psychology. New York: Oxford University Press; 1978.
   Google Scholar
• Lincoln YS, Guba EG. Naturalistic Inquiry. Beverly Hills: Sage; 1985.
   Google Scholar
• Pell C, Vernooij E, Masilela N, Simelane N, Shabalala F, Reis R. False starts in ‘test and start’: a qualitative study of reasons for delayed antiretroviral therapy in Swaziland. Int Health. 2018;10(2):78–83. doi:10.1093/inthealth/ihx065
   PubMed Web of Science ®Google Scholar
• Perlo J, Colocci I, Rajagopal SS, et al. The convergence of disclosure concerns and poverty contributes to loss to HIV care in India: a qualitative study. J Int Assoc Provid AIDS Care. 2020;19:2325958220934606.
   Google Scholar
• Ingabire PM, Semitala F, Kamya MR, Nakanjako D. Delayed antiretroviral therapy initiation among hospitalized adults in a resource-limited settings: challenge to the global target of ART for 90% of HIV-infected individuals. AIDS Res Treat. 2019;2019:1–8.
   Web of Science ®Google Scholar
• Boyer S, Iwuji C, Gosset A, et al. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa. AIDS Care. 2016;28(3):39–51. doi:10.1080/09540121.2016.1164808
   PubMed Web of Science ®Google Scholar
• Vernooij E, Mehlo M, Hardon A, Reis R. Access for all: contextualising HIV treatment as prevention in Swaziland. AIDS Care. 2016;28(3):7–13. doi:10.1080/09540121.2016.1178954
   PubMed Web of Science ®Google Scholar